Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry (REPOSE-2): A Multicenter Randomized Controlled Trial

NCT05728775 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT05728775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05728775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry (REPOSE-2): A Multicenter Randomized Controlled Trial
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Phase 4
Overall status
Recruiting
Start date
April 3, 2023
Completion date
December 31, 2027
Enrollment
7,188 (estimated)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, surgery-complications